Sunday, December 26, 2010

Carat Keeps $1.2 Billion Pfizer Media After Review


NEW YORK (AdAge.com) -- Pfizer is keeping its estimated $1.2 billion media planning and buying business at Aegis' Carat after a review that launched in September. The move comes after the pharma company earlier this year consolidated all media buying for its Wyeth DTC brands under Carat.


Source: http://feedproxy.google.com/~r/adage/homepage/~3/L2XH6-Cvy3E/article.php

advertising solutions internet advertising research advertising jobs local internet advertising

No comments:

Post a Comment